Subcutaneous, intranasal and transdermal dopamine agonists in the management of Parkinson’s disease
Figure 6.1 Structure of dopamine and rotigotine. Pharmacokinetics Rotigotine has a broad spectrum of action across the D1–D5 receptors (Table 6.3) [12]. This, particularly its D1 activity, is in theory…